A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Clinical trial NCT07466316 · RECRUITING

Trial details

NCT number: NCT07466316
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Rhabdomyosarcoma

Start date: 2026-07-14
Primary completion: 2031-03-31
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.